Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Equity

v3.23.1
Condensed Consolidated Statements of Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning balance at Dec. 31, 2021 $ 313,871 $ 4 $ 330,616 $ (26,436) $ 9,687
Beginning balance (in shares) at Dec. 31, 2021   38,871,646      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Transfer of Private Warrants to Public Warrants 605   605    
Net (loss) income 2,726     2,726  
Other comprehensive income, net of tax (2,227)       (2,227)
Stock-based compensation 1,354   1,354    
Net share settlements of stock-based awards (291)   (291)    
Net share settlements of stock-based awards (in shares)   146,444      
Shares issued for contingent consideration (in shares)   2,659,574      
Shares issued for payment of contingent consideration 23,936   23,936    
Ending balance at Mar. 31, 2022 339,974 $ 4 356,220 (23,710) 7,460
Ending balance (in shares) at Mar. 31, 2022   41,677,664      
Beginning balance at Dec. 31, 2022 $ 274,551 $ 4 360,777 (85,188) (1,042)
Beginning balance (in shares) at Dec. 31, 2022 41,994,355 41,994,355      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net (loss) income $ (19,797)     (19,797)  
Other comprehensive income, net of tax 4,404       4,404
Stock-based compensation 1,792   1,792    
Net share settlements of stock-based awards (405)   (405)    
Net share settlements of stock-based awards (in shares)   250,611      
Ending balance at Mar. 31, 2023 $ 260,545 $ 4 $ 362,164 $ (104,985) $ 3,362
Ending balance (in shares) at Mar. 31, 2023 42,244,966 42,244,966